Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-10-005808
Filing Date
2010-11-24
Accepted
2010-11-24 14:31:55
Documents
1
Period of Report
2010-11-23

Document Format Files

Seq Description Document Type Size
1 c63459_ex.html 4  
1 c63459_ex.xml 4 6933
  Complete submission text file 0000930413-10-005808.txt   9096
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUTICALS INC. RTE 202/206 BRIDGEWATER NJ 08807
Business Address
del Campo Ralph (Reporting) CIK: 0001323683 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 101214629